CARB-X is the world’s largest public-private partnership devoted to early development antibacterial R&D. CARB-X has announced the opening of its 2019 funding rounds to support the early development of antibiotics, vaccines, diagnostics and other life-saving products to respond to the threat of drug-resistant bacteria.
Please join NCBiotech and RTI International as we host CARB-X Global R&D Project Director Karen Gallant for an informational session about CARB-X and the upcoming funding rounds. Karen will provide an overview of the CARB-X initiative and leave plenty of time to get all questions answered. This event is FREE to attend.
For further information, please refer to the CARB-X press release and website.
10:00 a.m. - Presentation by Karen Gallant, Global R&D Project Director, CARB-X
10:30 a.m. - Presentation: RTI International as a CARB-X Accelerator
10:45 a.m. - Q&A Session
11:15 a.m. - Networking
11:45 a.m. - Adjourn
There is some availability for a few companies to have one-on-one meetings with CARB-X. If you are interested, please select that option on the registration page.
15 T.W. Alexander Drive
Research Triangle Park, NC 27709